HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Min-Young Noh Selected Research

Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)

1/2022Clinical and genetic characteristics of amyotrophic lateral sclerosis patients with ANXA11 variants.
10/2020ANXA11 mutations in ALS cause dysregulation of calcium homeostasis and stress granule dynamics.
1/2018Repeated Intrathecal Mesenchymal Stem Cells for Amyotrophic Lateral Sclerosis.
2/201725-Hydroxycholesterol is involved in the pathogenesis of amyotrophic lateral sclerosis.
1/2017Genetic and functional analysis of TBK1 variants in Korean patients with sporadic amyotrophic lateral sclerosis.
10/2014The immunomodulatory effects of human mesenchymal stem cells on peripheral blood mononuclear cells in ALS patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Min-Young Noh Research Topics

Disease

6Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
01/2022 - 10/2014
4Alzheimer Disease (Alzheimer's Disease)
11/2013 - 03/2009
3Ischemic Stroke
09/2018 - 06/2017
2Frontotemporal Dementia (Semantic Dementia)
02/2024 - 01/2022
2Disease Progression
11/2020 - 10/2014
2Stroke (Strokes)
09/2018 - 07/2018
2Necrosis
09/2018 - 06/2017
1Motor Neuron Disease (Primary Lateral Sclerosis)
11/2020
1Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
09/2018
1Brain Edema (Cerebral Edema)
09/2018
1Infarction (Infarctions)
09/2018
1Neurodegenerative Diseases (Neurodegenerative Disease)
09/2018
1Neuroinflammatory Diseases
09/2018
1Brain Injuries (Brain Injury)
06/2017
1Inflammation (Inflammations)
06/2017
1Lymphoma (Lymphomas)
05/2016
1B-Cell Lymphoma (Lymphoma, B Cell)
04/2016

Drug/Important Bio-Agent (IBA)

3Proteins (Proteins, Gene)FDA Link
10/2020 - 04/2016
3Poly (ADP-Ribose) Polymerase-1IBA
09/2018 - 06/2017
3Neuroprotective AgentsIBA
09/2018 - 11/2013
3JPI-289IBA
09/2018 - 06/2017
2CalciumIBA
01/2022 - 10/2020
2Amyloid beta-PeptidesIBA
11/2013 - 05/2013
2Cholinesterase Inhibitors (Anticholinesterases)IBA
11/2013 - 03/2009
2Glycogen Synthase (Synthase I)IBA
05/2013 - 10/2011
1DNA-Binding Proteins (DNA Binding Protein)IBA
02/2024
1ProgranulinsIBA
02/2024
1AnnexinsIBA
01/2022
1Dietary FiberFDA Link
11/2020
1Therapeutic UsesIBA
09/2018
1CytokinesIBA
07/2018
125-hydroxycholesterolIBA
02/2017
1HydroxycholesterolsIBA
02/2017
1Phosphotransferases (Kinase)IBA
01/2017
1Lysine (L-Lysine)FDA Link
05/2016
1lysyllysine (Lys-Lys)IBA
05/2016
1Caspase 3 (Caspase-3)IBA
04/2016
1Caspase 9IBA
04/2016
1Apoptosis Inducing FactorIBA
04/2016
1Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA
04/2016
1Poly Adenosine Diphosphate RiboseIBA
04/2016
1Reactive Oxygen Species (Oxygen Radicals)IBA
04/2016
1Cytochromes c (Cytochrome c)IBA
04/2016
1Superoxides (Superoxide)IBA
10/2014
1GlycogenIBA
11/2013
1Protein Phosphatase 2 (Protein Phosphatase 2A)IBA
11/2013
1Donepezil (Aricept)FDA LinkGeneric
11/2013
1tau-protein kinaseIBA
10/2011
1Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA
10/2011

Therapy/Procedure

2Spinal Injections
01/2018 - 10/2014
1Aftercare (After-Treatment)
07/2018